Universal Biosensors, Inc. (ASX:UBI)

Australia flag Australia · Delayed Price · Currency is AUD
0.0140
0.00 (0.00%)
Feb 13, 2026, 4:25 AM AEST
-90.00%
Market Cap 4.17M
Revenue (ttm) 5.95M
Net Income (ttm) -17.46M
Shares Out 298.07M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 132,045
Average Volume 615,066
Open 0.0140
Previous Close 0.0140
Day's Range 0.0130 - 0.0140
52-Week Range 0.0120 - 0.1600
Beta 0.21
RSI 30.96
Earnings Date May 11, 2026

About Universal Biosensors

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO₂, malic acid, glucose, fructose, total acid, and titratable acid... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2001
Employees 76
Stock Exchange Australian Securities Exchange
Ticker Symbol UBI
Full Company Profile

Financial Performance

In 2024, Universal Biosensors's revenue was 6.28 million, a decrease of -5.28% compared to the previous year's 6.63 million. Losses were -14.24 million, 111.2% more than in 2023.

Financial Statements

News

There is no news available yet.